Tau phosphorylation at Alzheimer's disease biomarker sites impairs its cleavage by lysosomal proteases
Alzheimer's & Dementia · 2025-06 · 21 (6)
DOI: 10.1002/alz.70320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 05.06.2025. Verfasst von Courtney Lane-Donovan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Memory and Aging Center, Weill Institute for Neuroscience, Department of Neurology, University of California, San Francisco, San Francisco, Californi…. Hauptthemen laut MEDLINE: tau Proteins, Alzheimer Disease, Lysosomes, Peptide Hydrolases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, American Brain Foundation, Alzheimer's Association.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Phospho‐tau peptides from the proline‐rich domain (PRD) of tau are sensitive biomarkers for Alzheimer's disease (AD). The PRD is known to be relatively resistant to lysosomal proteolytic cleavage, but the effects of phosphorylation on cleavage are unknown. METHODS Using in silico modeling and in vitro protease assays, we quantified the effects of phosphorylation on lysosomal proteolysis of tau. We further assessed levels of lysosomal proteases in patient‐derived cerebrospinal fluid (CSF) relative to phosphorylated tau‐181 (p‐tau181). RESULTS Phosphorylation renders the PRD significantly resistant to cleavage by the lysosome, especially at less acidic pH setpoints. In Alzheimer's disease subjects, CSF levels of lysosomal proteases correlate with p‐tau181, suggesting that p‐tau peptides are released with lysosomal contents. DISCUSSION Loss of lysosomal acidity may contribute to the release of phospho‐tau biomarkers. This study shows that phosphorylation of tau impairs its cleavage by proteases in a pH‐dependent manner and provides a novel molecular basis for p‐tau biomarker accumulation in AD. Highlights Phosphorylated tau‐181 (p‐tau181) and p‐tau217 originate from tau regions that are poorly cleaved by lysosomal proteases. Phosphorylation further impairs the proteolytic cleavage of AD biomarker peptides. Impaired proteolytic cleavage of phosphorylated tau is pH dependent. Levels of p‐tau181 are correlated with lysosomal proteases in Alzheimer's disease (AD) cerebrospinal fluid samples. AD‐associated lysosomal dysfunction may contribute to presence of disease biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Memory and Aging Center, Weill Institute for Neuroscience, Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
- Bakar Aging Research Institute, University of California, San Francisco, San Francisco, California, USA.
ORCID-Profile: Courtney Lane-Donovan, Aimee W Kao
Förderung
- NINDS NIH HHS
- American Brain Foundation
- Alzheimer's Association
- Rainwater Charitable Foundation
- Creative Minds Care, Weill Neurosciences Institute, Drew and Ellen Bradley, Bluefield Project to Cure FTD
- Association for Frontotemporal Degeneration
- NIA NIH HHS
- Paul G. Allen Frontiers Group
Zitieren
APA
Lane-Donovan, C., Smith, A. W., Saloner, R., Miller, B. L., Casaletto, K. B., & Kao, A. W. (2025). Tau phosphorylation at Alzheimer's disease biomarker sites impairs its cleavage by lysosomal proteases. Alzheimer's & Dementia, 21(6). https://doi.org/10.1002/alz.70320
Vancouver
Lane-Donovan C, Smith AW, Saloner R, Miller BL, Casaletto KB, Kao AW. Tau phosphorylation at Alzheimer's disease biomarker sites impairs its cleavage by lysosomal proteases. Alzheimer's & Dementia. 2025;21(6). doi:10.1002/alz.70320
BibTeX
@article{LaneDonovan2025,
author = {Lane-Donovan, Courtney and Smith, Andrew W and Saloner, Rowan and Miller, Bruce L and Casaletto, Kaitlin B and Kao, Aimee W},
title = {Tau phosphorylation at Alzheimer's disease biomarker sites impairs its cleavage by lysosomal proteases},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {6},
doi = {10.1002/alz.70320}
}
EUVIMED